Baring Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$3.72M Buy
43,492
+23,229
+115% +$1.91M 0.22% 61
2017
Q2
$1.67M Buy
+20,263
New +$1.65M 0.11% 97

Other funds holding LLY

Baring Asset Management's LLY Position: Q3 2017 in Review

Baring Asset Management increased its Eli Lilly (LLY) stake by 115% in Q3 2017, buying an estimated $1.91M and bringing the position to 43,492 shares worth $3.72M. The position accounts for 0.22% of the portfolio, ranked #61.

Baring Asset Management first reported a position in LLY in Q2 2017 and has held it in 2 quarters since. 1,228 funds tracked by Wall St. Rank hold LLY as of Q3 2017.

  • Baring Asset Management held 43,492 shares of Eli Lilly worth $3.72M as of Q3 2017.
  • Baring Asset Management bought 23,229 Eli Lilly shares in Q3 2017, an estimated $1.91M.
  • Eli Lilly made up 0.22% of Baring Asset Management's portfolio in Q3 2017, its #61 holding.
  • Baring Asset Management first reported a position in Eli Lilly in Q2 2017 and has held it in 2 quarters since.
  • 1,228 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2017.

Based on Baring Asset Management's 13F filing for Q3 2017, filed 26 Oct 2017.